Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT02641951
Other study ID # R/15.08.41
Secondary ID
Status Enrolling by invitation
Phase N/A
First received December 24, 2015
Last updated February 5, 2016
Start date November 2015
Est. completion date July 2016

Study information

Verified date February 2016
Source Mansoura University
Contact n/a
Is FDA regulated No
Health authority Egypt: Ministry of Higher Eduacaion
Study type Interventional

Clinical Trial Summary

Post mastectomy pain syndrome result from surgical damage to the intercostobrachial nerve, the lateral cutaneous branch of the second intercostal nerve that is often resected at mastectomy. result from surgical damage to the intercostobrachial nerve, the lateral cutaneous branch of the second intercostal nerve that is often resected at mastectomy, A second version of the pectoral nerve block is described, called ''modified Pecs block'' or Pecs block type II.

This novel approach aims to block at least the pectoral nerves, the intercostobrachial, intercostals III-IV-V-VI and the long thoracic nerve. These nerves need to be blocked to provide complete analgesia during breast surgery


Description:

The aim of this study is to evaluate the efficacy of ultrasound guided stellate ganglionic block alone versus stellate ganglionic block plus pecs II block in management of chronic postmastectomy pain ,patient will be trained to use visaual analog scale to describe their pain range of movement will be assessed using manual geniometry at post procedure visits at one month ,3 months and 6 months procedures in each group will done using ultrasound guidance mixture will be used.

All patients will be informed about the procedure and its possible consequences after detailed explanation of protocol of this study. Written informed consents will be obtained before the procedure.

With each block, an intravenous cannula will be inserted and secured. All suitable resuscitation equipment and drugs will be available. Vital signs (heart rate, blood pressure, and oxygen saturation) will be monitored throughout the procedure and up to 1 hour after the block performance. Midazolam 0.02 ug/kg will be administered intravenously as premedication.

Brief evaluation will be done for all patients with regard to their systemic diseases, general condition, and coagulation status.

All patients will be familiar with the use of 10-cm visual analogue scale score (VAS) identifying 0 as no pain and 10 as worst imaginable pain.Basal assessment of range of movement for abduction ,external rotation ,and forward flextion using manual geniometry and patients will be asked to complete Quality of life questionnaire


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 40
Est. completion date July 2016
Est. primary completion date May 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- American Society of Anesthesiologists physical status III or IV.

- Patients having irradiating pain of anterior chest wall and axilla after breast surgery.

- Patients having irradiating pain of ipsilateral arm after breast surgery

- Pain not responding to conservative treatment

- Pain persisting for more than 3 month

Exclusion Criteria:

- Local skin infection

- Coagulation or blood disease

- Pregnancy

- Postpartum or lactating females

- Allergy to the study medications.

- Severely altered consciousness level.

- Psychiatric disorder

- Drug abuse

- Spine or chest wall deformities

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Other:
Stellate ganglionic block
Ultrasound guided stellate ganglionic block
Pecs II block
Ultrasound guided Pecs II block

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Outcome

Type Measure Description Time frame Safety issue
Primary Pain scores 100 mm- visual analog pain scale for six months after the procedure No
Secondary The range of motion of the glenohumeral joint Improvements in the range of motion of the glenohumeral joint, which included forward extension and external rotation will be recorded using scoring system score 0 to 9 for some movements range and 0 to 160 for others for six months after the procedure No
Secondary The quality of life score The quality of life will be assessed using the score QOLSF 36 for six months after the procedure No